Cargando…
Platforms Exploited for SARS-CoV-2 Vaccine Development
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the only zoonotic-origin coronavirus (CoV) that has reached the pandemic stage. The virus uses its spike (S) glycoprotein to attach to the host cells and initiate a cascade of events that leads to infection. It has sternly aff...
Autores principales: | Mathew, Shilu, Faheem, Muhammed, Hassain, Neeraja A., Benslimane, Fatiha M., Al Thani, Asmaa A., Zaraket, Hassan, Yassine, Hadi M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824029/ https://www.ncbi.nlm.nih.gov/pubmed/33375677 http://dx.doi.org/10.3390/vaccines9010011 |
Ejemplares similares
-
Identification of potential natural inhibitors of the receptor-binding domain of the SARS-CoV-2 spike protein using a computational docking approach
por: Mathew, Shilu Mathew, et al.
Publicado: (2021) -
Epidemiological, Molecular, and Clinical Features of Norovirus Infections among Pediatric Patients in Qatar
por: Mathew, Shilu, et al.
Publicado: (2019) -
Computational screening of known broad-spectrum antiviral small organic molecules for potential influenza HA stem inhibitors
por: Mathew, Shilu, et al.
Publicado: (2018) -
Within-Host Diversity of SARS-CoV-2 in COVID-19 Patients With Variable Disease Severities
por: Al Khatib, Hebah A., et al.
Publicado: (2020) -
Vaccine evaluation and genotype characterization in children infected with rotavirus in Qatar
por: Mathew, Shilu, et al.
Publicado: (2023)